 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
Ian RH Rockett, PhD, MPH, Department of Community Medicine, West Virginia University, PO Box 9190, Morgantown, WV 26506-9190, 304-293 2502, irockett@utk.edu, Sandra L Putnam, PhD, Community Health Research Group, University of Tennessee, 600 Henley Street, Knoxville, TN 37996-3400, Haomiao Jia, PhD, Department of Community Health and Social Medicine, City University of New York, 138th Street and Convent Avenue, Room A109, New York, NY 10031, and Gordon S Smith, MBChB, MPH, Liberty Center for Safety Research, 71 Frankland Rd, Boston, MA 01748.
Impacting diagnosis, therapy and prognosis, little is known about denial of psychoactive drug use within the hospital emergency department (ED) population. This research documents undeclared drug use among adult Tennessee ED patients. A two-stage probability procedure yielded a statewide sample of 7 hospitals and 1,502 cases. Data sources were ED logs, personal interviews, and rapid assay saliva and urine tests. Test positivity was: 31% - any drug, 15% - marijuana, 11% - tranquilizers, 9% - opioids, 6% - stimulants, 5% - alcohol and cocaine, 3% - sedatives, and 1% - hallucinogens. Of test-positive patients, 32% denied drug use in the past 30 days, 20% in the past 12 months, and 10% lifetime. Ten percent of alcohol test-positives denied use in the past 30 days. For other drug use, denial ranged from 57% for marijuana to 100% for hallucinogens. Results support factoring denial into drug treatment needs assessment.
Learning Objectives:
Keywords: Emergency Department/Room, Substance Abuse Assessment
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.